What is the current price for "When will Intellia Therapeutics submit a BLA for Lonvo-z?"?

The leading outcome "Yes" is currently trading at 71.5% probability.

How many markets are available for "When will Intellia Therapeutics submit a BLA for Lonvo-z?"?

There are 6 markets available for this event on Kalshi.

What is the trading volume for "When will Intellia Therapeutics submit a BLA for Lonvo-z?"?

Trading volume data is not currently available.

BackKKALSHI

When will Intellia Therapeutics submit a BLA for Lonvo-z?

Yes78%

Vol$0.00

Markets6

78%

TradeTrade on Kalshi

Event Group

EventKALSHI

Single EventKALSHIScience and Technology

When will Intellia Therapeutics submit a BLA for Lonvo-z?

Name: When will Intellia Therapeutics submit a BLA for Lonvo-z?
Start: 2026-07-10T08:08:02.471Z
End: 2026-08-09T08:08:02.471Z

Part of: When will Intellia Therapeutics submit a BLA for Lonvo-z?

Lonvoguran Ziclumeran (lonvo-z) - BLA If Intellia Therapeutics, Inc. submits a BLA for Lonvoguran Ziclumeran, lonvo-z, to the FDA before X 1, 2027, then the market resolves to Yes. Early close condition: This market will close and expire early if the event occurs. This market will close and expire early if the event occurs.

YesLeading Yes Probability

78%

VolTotal Volume

$0.00

Markets

Trade on Kalshi

When will Intellia Therapeutics submit a BLA for Lonvo-z?

Yes

78%

Vol

$0.00

Markets

Trade

Market Price Graph

6 markets tracked

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before April 2027)

kalshi

No data available

All Markets(6)

Market	Price
When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before April 2027)	78%
When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before 2027)	72%
When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before December)	71%
When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before November)	64%
When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before October)	54%

Markets (6)

Sort

KALSHITech

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before April 2027)

If Intellia Therapeutics, Inc. submits a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA before Apr 1, 2027, then the market resolves to Yes. Early close condition: This market will close and expire early if the event occurs.

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before 2027)

If Intellia Therapeutics, Inc. submits a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA before Jan 1, 2027, then the market resolves to Yes. Early close condition: This market will close and expire early if the event occurs.

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before December)

If Intellia Therapeutics, Inc. submits a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA before Dec 1, 2026, then the market resolves to Yes. Early close condition: This market will close and expire early if the event occurs.

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before November)

If Intellia Therapeutics, Inc. submits a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA before Nov 1, 2026, then the market resolves to Yes. Early close condition: This market will close and expire early if the event occurs.

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before October)

If Intellia Therapeutics, Inc. submits a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA before Oct 1, 2026, then the market resolves to Yes. Early close condition: This market will close and expire early if the event occurs.

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before September)

If Intellia Therapeutics, Inc. submits a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA before Sep 1, 2026, then the market resolves to Yes. Early close condition: This market will close and expire early if the event occurs.

When will Intellia Therapeutics submit a BLA for Lonvo-z?

When will Intellia Therapeutics submit a BLA for Lonvo-z?

When will Intellia Therapeutics submit a BLA for Lonvo-z?

Market Price Graph

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before April 2027)

Rules & Resolution Criteria

Markets (6)

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before April 2027)

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before 2027)

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before December)

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before November)

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before October)

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before September)

Share This Event